Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Cellectar Biosciences, Inc. (CLRB)
|
Add to portfolio |
|
|
|
| Price: |
$0.71
| | Metrics |
| OS: |
9.74
|
M
| |
|
|
| Market cap: |
$6.87
|
M
| |
|
|
|
Net cash:
|
$5.18
|
M
| |
$0.53
|
per share
|
|
EV:
|
$1.69
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 |
| Gross margin | | | | | | | | |
| Research and development | 19.2 | 17.6 | 10.1 | 9.0 | 6.8 | 9.5 | 4.8 | 5.2 |
| General and administrative | 9.6 | 6.5 | 5.1 | 5.2 | 4.8 | 4.1 | 4.7 | 3.4 |
| EBIT | -28.8 | -24.1 | -15.3 | -14.2 | -11.7 | -13.6 | -9.4 | -8.8 |
| EBIT margin | | | | | | | | |
| Pre-tax income | -28.7 | -24.1 | -15.1 | -14.1 | -13.2 | -13.6 | -6.2 | -5.5 |
| Income taxes | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -28.6 | -24.1 | -15.1 | -14.1 | -15.5 | -15.0 | -9.4 | -5.5 |
| Net margin | | | | | | | | |
| |
| Diluted EPS | ($4.05) | ($4.35) | ($0.76) | ($1.84) | ($5.23) | ($10.70) | ($2.14) | ($7.03) |
| Shares outstanding (diluted) | 7.1 | 5.6 | 19.8 | 7.7 | 3.0 | 1.4 | 4.4 | 0.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|